| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,471,016 |
|
|
|
Indirect Value
|
$4,283,565 |
|
|
| Total
Shares |
3,393,580 |
|
|
| Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 16 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-02-23 |
4 |
OE |
$0.78 |
$9,803 |
D/D |
12,552 |
39,152 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-02-23 |
4 |
AS |
$41.00 |
$514,632 |
D/D |
(12,552) |
26,600 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-05 |
4 |
OE |
$4.94 |
$64,056 |
D/D |
12,972 |
29,268 |
|
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-03-03 |
4 |
AS |
$24.53 |
$334,859 |
I/I |
(13,651) |
87,805 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2014-05-12 |
4 |
B |
$1.83 |
$25,522 |
I/I |
13,925 |
317,925 |
2.1 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2005-04-27 |
4 |
OE |
$7.13 |
$101,132 |
D/D |
14,194 |
41,636 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2004-08-27 |
4 |
OE |
$7.13 |
$103,498 |
D/D |
14,526 |
31,842 |
|
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-01-24 |
4 |
AS |
$35.37 |
$518,281 |
I/I |
(14,631) |
117,562 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2018-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
15,000 |
42,287 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-10-08 |
4 |
AS |
$53.89 |
$808,823 |
I/I |
(15,000) |
818,578 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-10-09 |
4 |
AS |
$54.60 |
$819,177 |
I/I |
(15,000) |
803,578 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-12-28 |
4 |
AS |
$71.58 |
$1,094,616 |
I/I |
(15,000) |
746,191 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-12-29 |
4 |
AS |
$64.78 |
$996,167 |
I/I |
(15,000) |
731,191 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-01-20 |
4 |
AS |
$35.13 |
$550,256 |
I/I |
(15,604) |
121,477 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-01-04 |
4/A |
AS |
$43.02 |
$699,104 |
I/I |
(16,053) |
130,930 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-01-04 |
4 |
AS |
$43.04 |
$712,607 |
I/I |
(16,353) |
130,687 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-01-05 |
4 |
AS |
$40.44 |
$689,057 |
I/I |
(16,353) |
126,312 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-29 |
4 |
AS |
$20.13 |
$349,008 |
I/I |
(17,342) |
60,222 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-05-04 |
4 |
AS |
$21.29 |
$382,668 |
I/I |
(17,643) |
79,276 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-01-04 |
4 |
AS |
$20.40 |
$371,749 |
I/I |
(18,223) |
43,591 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-02-01 |
4 |
AS |
$26.98 |
$538,820 |
I/I |
(19,826) |
93,840 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-03-04 |
4 |
AS |
$20.44 |
$482,285 |
I/I |
(23,323) |
25,915 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-05-06 |
4 |
AS |
$24.64 |
$574,679 |
I/I |
(23,323) |
9,981 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-07-26 |
4 |
D |
$30.80 |
$746,840 |
D/D |
(24,252) |
97,945 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• • – |
2010-11-22 |
4 |
OE |
$11.13 |
$278,125 |
I/I |
25,000 |
74,573 |
0 |
- |
|
424 Records found
|
|
Page 16 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
